Comparing Bosulif vs Sprycel
Bosulif | Sprycel |
|
---|
Bosulif (bosutinib) | Sprycel (dasatinib) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Chronic Myelogenous Leukemia. Bosulif may also be used for purposes not listed in this medication guide. |
Prescription only
Sprycel is an oral tyrosine kinase inhibitor that works by inhibiting multiple conformations of the ABL kinase which is an abnormal enzyme involved in the development of blood cancers such as Ph+ CML... View more |
||||||||||||||||
More about Bosulif (bosutinib) | More about Sprycel (dasatinib) | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Bosulif has an average rating of 7.3 out of 10 from a total of 6 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 25% reported a negative effect. |
Sprycel has an average rating of 7.5 out of 10 from a total of 21 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 19% reported a negative effect. |
||||||||||||||||
Drug Class | |||||||||||||||||
Side Effects | |||||||||||||||||
See also: Bosulif side effects in more detail. |
See also: Sprycel side effects in more detail. |
||||||||||||||||
Generic Availability | |||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Bosulif prices |
View all Sprycel prices |
||||||||||||||||
Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
N/A |
Other dasatinib brands include: Phyrago | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
22.5 hours |
5 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 533 drugs are known to interact with Bosulif:
|
A total of 769 drugs are known to interact with Sprycel:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
September 04, 2012 |
June 28, 2006 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.